Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-04

FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Vitruvias Therapeutics)

View source ↗

Summary

FDA approved Propafenone hydrochloride as an Abbreviated New Drug Application (ANDA) for a generic antiarrhythmic, with Vitruvias Therapeutics as the manufactur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propafenone hydrochloride (Propafenone hydrochloride)

Snippet

ORIG AP for PROPAFENONE HYDROCHLORIDE (PROPAFENONE)